pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

7,774 catalysts · 5,159 phase readout · 2,297 8k filing · 315 pdufa · 257 earnings · 2 approval · 1 adcom

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-27: 0 catalysts2026-07-28: 0 catalysts2026-07-29: 0 catalysts2026-07-30: 25 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 13 catalysts2026-08-05: 16 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 1 catalyst2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 1 catalyst2026-10-21: 0 catalysts2026-10-22: 2 catalysts2026-10-23: 0 catalysts2026-10-24: 0 catalysts2026-10-25: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type
  • phase readout5,159
  • 8k filing2,297
  • pdufa315
  • earnings257
  • approval2
  • adcom1
therapy area

no tagged catalysts yet

Date TBD

50
›RECRUITINGphase readoutNCT06166537: GRACE: Evaluating Compression Stockings in Patients That Require Extended Duration Pharmacological Thromboprophylaxis

Sponsor: Imperial College London. Phase: NA. Conditions: Venous Thromboembolism, Surgery

full page →ctgov ↗
›RECRUITINGphase readoutNCT03816345: Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

Sponsor: National Cancer Institute (NCI). Phase: PHASE1. Conditions: Autoimmune Disease, Crohn Disease, Dermatomyositis, Hematopoietic and Lymphoid Cell Neoplasm, Inflammatory Bowel Disease, Malignant Solid Neoplasm, Multiple Sclerosis, Psoriasis, Psoriatic Arthritis, Rheumatoid Arthritis, Sjogren Syndrome, Systemic Lupus Erythematosus, Systemic Scleroderma, Ulcerative Colitis

full page →ctgov ↗
›RECRUITINGphase readoutNCT06563895: Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant

Sponsor: Eidos Therapeutics, a BridgeBio company. Phase: PHASE3. Conditions: Amyloidosis, Amyloid Cardiomyopathy, Transthyretin Amyloidosis, Cardiomyopathies, Heart Diseases, Polyneuropathies

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT07320677: Finding Heart Failure in Those Prescribed Loop Diuretics in Primary Care in Jersey

Sponsor: Government of Jersey. Phase: NA. Conditions: Heart Failure, Diuretics

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07523412: Dimensional Changes of Peri-implant Tissues Following Jumping Gap Grafting Using Erythropoietin Gel Mixed With Xenograft.

Sponsor: Ain Shams University. Phase: PHASE4. Conditions: Peri-implant Bone and Soft Tissues

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07323381: Effects of Henagliflozin Proline and Metformin XR on Body Composition in Geriatric Patients With Newly Diagnosed T2DM

Sponsor: Bin Lu. Phase: PHASE4. Conditions: Diabetes Type 2

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07533981: ¹²⁹Xe(XENON) MRI Program

Sponsor: Alexei Ouriadov. Phase: NA. Conditions: Healthy Volunteers - Male and Female

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT02598219: Evaluation of Sentinel Node Policy in Early Stage Endometrial Carcinomas at Intermediate and High Risk of Recurrence.

Sponsor: Centre Oscar Lambret. Phase: PHASE3. Conditions: Non Endometrioid Carcinoma, Endometrioid Carcinoma

full page →ctgov ↗
›RECRUITINGphase readoutNCT04702581: A Randomized Trial of Delayed Radiotherapy in Patients Low-grade Oligodendrogliomas Requiring a Treatment Other Than Surgery

Sponsor: Hospices Civils de Lyon. Phase: PHASE3. Conditions: Oligodendroglioma, Low-grade Oligodendroglioma, 1p19q Codeletion

full page →ctgov ↗
›TERMINATEDphase readoutNCT05036681: A Phase II Study of Futibatinib and Pembrolizumab in Metastatic Microsatellite Stable Endometrial Carcinoma

Sponsor: M.D. Anderson Cancer Center. Phase: PHASE2. Conditions: Metastatic Cancer, Endometrium Cancer, Endometrial Carcinoma

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07475819: Posture Exercises and Ergonomics Education

Sponsor: Bahçeşehir University. Phase: NA. Conditions: Work Related Musculoskeletal Disorders, Ergonomic Risk Exposure, Postural Disorders

full page →ctgov ↗
›COMPLETEDphase readoutNCT03358719: DEC-205/NY-ESO-1 Fusion Protein CDX-1401, Poly ICLC, Decitabine, and Nivolumab in Treating Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia

Sponsor: Roswell Park Cancer Institute. Phase: PHASE1. Conditions: Acute Myeloid Leukemia, Blasts 30 Percent or Less of Bone Marrow Nucleated Cells, Chronic Myelomonocytic Leukemia, High Risk Myelodysplastic Syndrome, Myelodysplastic Syndrome, Refractory Anemia

full page →ctgov ↗
›RECRUITINGphase readoutNCT05966519: ROSA Knee Intraoperative Planning Flexibility Study

Sponsor: Zimmer Biomet. Phase: . Conditions: Osteo Arthritis Knee, Rheumatoid Arthritis

full page →ctgov ↗
›COMPLETEDphase readoutNCT04648930: Special Drug Use Observational Study of Xolair in Patients With Severe to Most Severe Seasonal Allergic Rhinitis Aged ≥ 12 Years and < 18 Years Whose Symptoms Were Inadequately Controlled Despite to Conventional Therapies

Sponsor: Novartis Pharmaceuticals. Phase: . Conditions: Allergic Rhinitis

full page →ctgov ↗
›RECRUITINGphase readoutNCT05185128: Neural Basis of Social Cognition Deficits

Sponsor: Loma Linda University. Phase: NA. Conditions: Autism Spectrum Disorder, Psychosis, Social Communication

full page →ctgov ↗
›RECRUITINGphase readoutNCT03439865: Ivacaftor for Acquired CFTR Dysfunction in Chronic Rhinosinusitis

Sponsor: University of Alabama at Birmingham. Phase: EARLY_PHASE1. Conditions: Chronic Rhinosinusitis (Diagnosis)

full page →ctgov ↗
›RECRUITINGphase readoutNCT07389967: Nutrition Awareness Among Women With Non-Metastatic Breast Cancer

Sponsor: UNC Lineberger Comprehensive Cancer Center. Phase: NA. Conditions: Breast Cancer, Breast Cancer Metastatic

full page →ctgov ↗
›RECRUITINGphase readoutNCT07487467: Autologous SVF Therapy for Type 2 Diabetes

Sponsor: Kaiser Clinic and Hospital. Phase: NA. Conditions: Diabetes Mellitus, Type 2

full page →ctgov ↗
›RECRUITINGphase readoutNCT06630000: Focused Acceptance and Commitment Therapy (FACT)

Sponsor: Children's Mercy Hospital Kansas City. Phase: NA. Conditions: Pediatric Feeding Disorders

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07436507: Effects of a Combined Home-Based Exercise Program on Dual-Task Gait Performance, EEG Markers of Cognitive-Motor Control, and Pain in Females With Primary Dysmenorrhea: A Randomized Controlled Trial

Sponsor: University of Sharjah. Phase: NA. Conditions: Dysmenorrhea Primary

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07395492: App-Based Education and Low-Residue Diet for Colonoscopy Preparation

Sponsor: Chang Gung Memorial Hospital. Phase: NA. Conditions: Bowel Preparation Solution

full page →ctgov ↗
›RECRUITINGphase readoutNCT07018336: Mirror vs Virtual Reality Therapy for Upper Extremity Function in Hemiplegic Patients

Sponsor: Istinye University. Phase: NA. Conditions: Hemiplegia, Stroke, Upper Extremity Dysfunction

full page →ctgov ↗
›TEMPORARILY_NOT_AVAILABLEphase readoutNCT06383611: Expanded Access to Cyclic Irrigation in Patients Undergoing Exchange Arthroplasty

Sponsor: Osteal Therapeutics, Inc.. Phase: . Conditions: Prosthetic-joint Infection

full page →ctgov ↗
›RECRUITINGphase readoutNCT03838536: Synergistic Activity of Human Milk Nutrients and Infant Cognition

Sponsor: University of North Carolina, Chapel Hill. Phase: NA. Conditions: Breastfeeding, Exclusive

full page →ctgov ↗
›COMPLETEDphase readoutNCT01048736: Investigating Fitness Interventions in the Elderly (INFINITE)

Sponsor: Wake Forest University Health Sciences. Phase: NA. Conditions: Obesity, Older Adults, Sedentary

full page →ctgov ↗
›RECRUITINGphase readoutNCT07029711: A Study to Learn About Medicine Called Ritlecitinib in Children Aged Between 6 to 12 Years With Severe Alopecia Areata

Sponsor: Pfizer. Phase: PHASE3. Conditions: Severe Alopecia Areata

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07447271: Ultrasound Guided Cervical Selective Nerve Root Block Versus Fluoroscopic Guided Cervical Transforaminal Epidural Block

Sponsor: Pusan National University Yangsan Hospital. Phase: NA. Conditions: Cervical Radiculopathy

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT01898494: Transoral Surgery Followed By Low-Dose or Standard-Dose Radiation Therapy With or Without Chemotherapy in Treating Patients With HPV Positive Stage III-IVA Oropharyngeal Cancer

Sponsor: ECOG-ACRIN Cancer Research Group. Phase: PHASE2. Conditions: Human Papilloma Virus Infection, Stage III Squamous Cell Carcinoma of the Oropharynx, Stage IVA Squamous Cell Carcinoma of the Oropharynx, Stage IVB Squamous Cell Carcinoma of the Oropharynx

full page →ctgov ↗
›RECRUITINGphase readoutNCT07394166: Balancing Emotions and Electronics: A Pilot Intervention for Preschoolers

Sponsor: Boston Children's Hospital. Phase: NA. Conditions: Screen Media Use

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07491666: Effects of Neuromuscular Exercises on Motor Skills in Girls

Sponsor: University of Novi Sad. Phase: NA. Conditions: Motor Skills, Locomotor Activity, Objective Control Skills

full page →ctgov ↗
›RECRUITINGphase readoutNCT07173166: Non-Pharmacological Interventions for Neurotoxicity in Hematologic Patients Receiving CAR-T Therapy

Sponsor: Instituto de Investigacion Sanitaria INCLIVA. Phase: NA. Conditions: Hematologic Cancer

full page →ctgov ↗
›COMPLETEDphase readoutNCT00024622: PET Scanning in Parkinson s Disease

Sponsor: National Institute of Mental Health (NIMH). Phase: . Conditions: Schizophrenia, Parkinson's Disease

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07486102: A Study to Test How BI 3000202 is Taken up in the Blood of People With and Without Liver Problems

Sponsor: Boehringer Ingelheim. Phase: PHASE1. Conditions: Healthy, Hepatic Impairment

full page →ctgov ↗
›RECRUITINGphase readoutNCT06853002: Deep Breathing Exercises and Incentive Spirometry After Rib Fracture

Sponsor: Samsun University. Phase: NA. Conditions: Rib Fractures, Oxygenation

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07495137: The Improvement Effect of Real-time Artificial Intelligence Assisted Identification of Bleeding Points on Hemostasis Efficiency in Endoscopic Submucosal Dissection

Sponsor: Qilu Hospital of Shandong University. Phase: NA. Conditions: Endoscopic Submucosal Dissection, Endoscopic Submucosal Dissection (ESD)

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07145437: Prostate Stereotactic Radiation and Radio-induced Lymphocyte Apoptosis for Predicting Late Toxicities in Prostate Cancer (PROSTERA)

Sponsor: Clinique Sainte Clotilde. Phase: NA. Conditions: Prostate Cancer

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05729945: Catholic Health Initiatives (CHI) St. Joseph's Children Home Visiting Longitudinal Study

Sponsor: University of New Mexico. Phase: NA. Conditions: Child Development, Child Behavior, Child Abuse, Child Neglect, Parenting, Delinquency, Criminal Behavior

full page →ctgov ↗
›RECRUITINGphase readoutNCT05746039: Feasibility of Semaglutide in Advanced Lung Disease

Sponsor: University of Pennsylvania. Phase: PHASE1. Conditions: Obesity, Interstitial Lung Disease, Chronic Obstructive Pulmonary Disease, Sarcoidosis, Pulmonary, Pulmonary Hypertension

full page →ctgov ↗
›RECRUITINGphase readoutNCT05756777: A Study of Gilteritinib in Combination With Ivosidenib or Enasidenib in People With Acute Myeloid Leukemia (AML)

Sponsor: Memorial Sloan Kettering Cancer Center. Phase: PHASE1. Conditions: Acute Myeloid Leukemia (AML)

full page →ctgov ↗
›RECRUITINGphase readoutNCT06282601: STUDY OF THE EFFECT OF RHYTHMIC AND NON-RHYTHMIC MUSICAL PRIMING ON THE SYNTAX CAPACITY OF PRESBYACOUSTIC OLDER ADULTS

Sponsor: Centre Hospitalier Universitaire Dijon. Phase: NA. Conditions: Presbyacousie

full page →ctgov ↗
›RECRUITINGphase readoutNCT07114601: A Study of LY4257496 in Participants With Cancer (OMNIRAY)

Sponsor: Eli Lilly and Company. Phase: PHASE1. Conditions: Breast Neoplasms, Colorectal Neoplasms, Prostate Neoplasm, Endometrial Neoplasms, Neoplasm Metastasis

full page →ctgov ↗
›COMPLETEDphase readoutNCT05929001: Lymphedema Specific PROs for Risk Assessment, Prevention and Early Detection

Sponsor: University of Miami. Phase: . Conditions: Lymphedema

full page →ctgov ↗
›COMPLETEDphase readoutNCT03136601: Percutaneous Tibial Nerve Stimulation Maintenance: Monthly Therapy or Per Patient Requested Need

Sponsor: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center. Phase: NA. Conditions: Overactive Bladder

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05306301: Ponatinib Plus Chemotherapy in Acute Lymphoblastic Leukemia Patients

Sponsor: Gruppo Italiano Malattie EMatologiche dell'Adulto. Phase: PHASE2. Conditions: Chemotherapy, Leukemia, Acute Lymphoblastic

full page →ctgov ↗
›RECRUITINGphase readoutNCT07203001: A Phase II Trial to Evaluate the Clinical Efficacy, Safety and Tolerability of MAS825 in Pediatric and Adult Participants With Still's Disease

Sponsor: Novartis Pharmaceuticals. Phase: PHASE2. Conditions: Still´s Disease

full page →ctgov ↗
›RECRUITINGphase readoutNCT06410001: CE-STAND: Cervical Epidural STimulation After Neurologic Damage

Sponsor: University of Minnesota. Phase: PHASE1. Conditions: Spinal Cord Injury

full page →ctgov ↗
›RECRUITINGphase readoutNCT07535801: Recording Stress Biomarkers in Autism Spectrum Disorders

Sponsor: Universite Cote d'Azur. Phase: . Conditions: Autism Spectrum Disorder With Intellectual Deficiency

full page →ctgov ↗
›RECRUITINGphase readoutNCT06149481: Phase I/II Study of the Combination Immunotherapy Regimen: SX-682, TriAdeno Vaccine, Retifanlimab and IL-15 Agonist N-803 (STAR15) for Metastatic Colorectal Cancer (mCRC)

Sponsor: National Cancer Institute (NCI). Phase: PHASE1. Conditions: Metastatic Colorectal Cancer

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT03947619: Primary Unloading and Delayed Reperfusion in ST-Elevation Myocardial Infarction: The STEMI-DTU Trial

Sponsor: Abiomed Inc.. Phase: NA. Conditions: ST Elevation (STEMI) Myocardial Infarction of Anterior Wall

full page →ctgov ↗
›COMPLETEDphase readoutNCT07336030: Effect of Baduanjin Exercise in Diabetic Patients

Sponsor: Cairo University. Phase: NA. Conditions: Diabetes Mellitus

full page →ctgov ↗
← prev
page 56 of 156
next →